Last updated: July 17, 2026

Application No. 18/757,660

DISSOLVABLE SOLID CLEANSING ARTICLES CONTAINING SULFONATE-CONTAINING ANIONIC SURFACTANTS

Non-Final OA

Filed

Jun 28, 2024

Priority

Jun 28, 2023 — provisional 63/510,668

Examiner

ROBERTS, LEZAH

Art Unit

1612

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

The Procter & Gamble Company

OA Round

1 (Non-Final)

This examiner grants 49% of cases after interview

— +35.8% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 764 resolved cases, 2023–2026

Examiner Intelligence

ROBERTS, LEZAH View full profile →

Grants 49% of resolved cases

Career Allowance Rate

373 granted / 764 resolved

-11.2% vs TC avg

Strong +36% interview lift

Without

With

+35.8%

Interview Lift

resolved cases with interview

Typical timeline

4y 1m

Avg Prosecution

51 currently pending

Career history

838

Total Applications

across all art units

Statute-Specific Performance

§101

0.1%

-39.9% vs TC avg

§103

77.9%

+37.9% vs TC avg

§102

3.9%

-36.1% vs TC avg

§112

2.1%

-37.9% vs TC avg

Black line = Tech Center average estimate • Based on career data from 764 resolved cases

Prosecution Timeline

Jun 28, 2024

Application Filed

Apr 13, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/297,933

Patent 12661309

PREPARATION AND EFFICACY OF TOOTH WHITENING TABLET INCLUDING SHMP

5y 0m to grant Granted Jun 23, 2026

17/250,411

Patent 12594229

Personal Care Compositions and Methods for the Same

5y 2m to grant Granted Apr 07, 2026

18/462,651

Patent 12594241

TOPIRAMATE ORAL LIQUID SUSPENSION AND USE THEREOF

2y 7m to grant Granted Apr 07, 2026

17/225,146

Patent 12582583

ORAL CARE PRODUCT COMPRISING AN ORAL CARE RHEOLOGICAL SOLID COMPOSITION

4y 11m to grant Granted Mar 24, 2026

18/568,222

Patent 12558387

MULTI-VIRUS ANTI-INFECTIVITY AND PRO-IMMUNITY ASSEMBLY

2y 2m to grant Granted Feb 24, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

49%

Grant Probability

85%

With Interview (+35.8%)

4y 1m (~2y 1m remaining)

Median Time to Grant

Low

PTA Risk

Based on 764 resolved cases by this examiner. Grant probability derived from career allowance rate.